{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T05:23:34Z","timestamp":1770355414559,"version":"3.49.0"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"58","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,17]]},"DOI":"10.18632\/oncotarget.21550","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T20:40:30Z","timestamp":1507322430000},"page":"98280-98297","source":"Crossref","is-referenced-by-count":31,"title":["Gremlin-1 is a key regulator of the invasive cell phenotype in mesothelioma"],"prefix":"10.18632","volume":"8","author":[{"given":"Miao","family":"Yin","sequence":"first","affiliation":[{"name":"Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland"},{"name":"Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Tissari","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland"},{"name":"Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenni","family":"Tamminen","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland"},{"name":"Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Ylivinkka","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"R\u00f6nty","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Helsinki and Fimlab Laboratories, Pathology, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernilla","family":"von Nandelstadh","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Genome Scale Biology, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaisa","family":"Lehti","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Genome Scale Biology, University of Helsinki, Helsinki, Finland"},{"name":"K. Albin Johansson Foundation, Finnish Cancer Institute, Helsinki, Finland"},{"name":"Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Hyyti\u00e4inen","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Genome Scale Biology, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjukka","family":"Myll\u00e4rniemi","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, University of Helsinki and Helsinki University Hospital, Heart and Lung Center, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katri","family":"Koli","sequence":"additional","affiliation":[{"name":"Research Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland"},{"name":"Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ajpath.2012.12.028","article-title":"New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas","volume":"182","author":"Hassan","year":"2013","journal-title":"Am J Pathol"},{"key":"2","first-page":"718","article-title":"Latent period for malignant mesothelioma of occupational origin","volume":"34","author":"Buncher","year":"1992","journal-title":"J Occup Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ajim.20282","article-title":"Finnish Institute of Occupational Health (FIOH): prevention and detection of asbestos-related diseases, 1987-2005","volume":"49","author":"Rantanen","year":"2006","journal-title":"Am J Ind Med"},{"key":"4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature20785","article-title":"Early dissemination seeds metastasis in breast cancer","volume":"540","author":"Guzvic","year":"2016","journal-title":"Nature"},{"key":"5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/BJ20140771","article-title":"Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7","volume":"466","author":"Brazil","year":"2015","journal-title":"Biochem J"},{"key":"6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1165\/rcmb.2009-0101TR","article-title":"Role of gremlin in the lung: development and disease","volume":"42","author":"McLoughlin","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7","doi-asserted-by":"crossref","first-page":"15418","DOI":"10.1073\/pnas.0707210104","article-title":"Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors","volume":"104","author":"Chen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"8","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2010-06-291930","article-title":"Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2","volume":"116","author":"Presta","year":"2010","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ijcard.2014.08.051","article-title":"Gremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival","volume":"176","author":"Gawaz","year":"2014","journal-title":"Int J Cardiol"},{"key":"10","doi-asserted-by":"crossref","first-page":"14842","DOI":"10.1073\/pnas.0606857103","article-title":"Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation","volume":"103","author":"Brown","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2407-6-74","article-title":"The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein","volume":"6","author":"Kim","year":"2006","journal-title":"BMC Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/oncsis.2013.29","article-title":"Gremlin-1 associates with fibrillin microfibrils in vivo and regulates mesothelioma cell survival through transcription factor slug","volume":"2","author":"Koli","year":"2013","journal-title":"Oncogenesis"},{"key":"13","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/bjc.2012.519","article-title":"Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells","volume":"107","author":"Eisenbauer","year":"2012","journal-title":"Br J Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/rccm.200706-945OC","article-title":"Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis","volume":"177","author":"Koli","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"15","first-page":"802841","article-title":"Gremlin activates the Smad pathway linked to epithelial mesenchymal transdifferentiation in cultured tubular epithelial cells","volume":"2014","author":"Ruiz-Ortega","year":"2014","journal-title":"BioMed Res Int"},{"key":"16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yexcr.2014.12.010","article-title":"Overexpression of activin-A and -B in malignant mesothelioma - attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth","volume":"332","author":"Koli","year":"2015","journal-title":"Exp Cell Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nprot.2012.053","article-title":"Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection","volume":"7","author":"Bonfil","year":"2012","journal-title":"Nat Protoc"},{"key":"18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.18632\/oncotarget.13518","article-title":"Gremlin promotes retinal pigmentation epithelial (RPE) cell proliferation, migration and VEGF production via activating VEGFR2-Akt-mTORC2 signaling","volume":"8","author":"Qian","year":"2017","journal-title":"Oncotarget"},{"key":"19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/hsz-2014-0221","article-title":"Bone morphogenetic protein antagonist gremlin-1 regulates colon cancer progression","volume":"396","author":"Diamandis","year":"2015","journal-title":"Biol Chem"},{"key":"20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3750","article-title":"Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche","volume":"21","author":"Clark","year":"2015","journal-title":"Nat Med"},{"key":"21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.molonc.2014.04.004","article-title":"Expression patterns of bone morphogenetic protein antagonists in colorectal cancer desmoplastic invasion fronts","volume":"8","author":"Diamandis","year":"2014","journal-title":"Mol Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1159\/000443035","article-title":"Gremlin-1 C-Terminus Regulates Function of Macrophage Migration Inhibitory Factor (MIF)","volume":"38","author":"Gawaz","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"23","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/jcb.24094","article-title":"Asbestos exposure induces alveolar epithelial cell plasticity through MAPK\/Erk signaling","volume":"113","author":"Koli","year":"2012","journal-title":"J Cell Biochem"},{"key":"24","doi-asserted-by":"crossref","first-page":"e42264","DOI":"10.1371\/journal.pone.0042264","article-title":"Gremlin is overexpressed in lung adenocarcinoma and increases cell growth and proliferation in normal lung cells","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2369-14-33","article-title":"Gremlin induces cell proliferation and extra cellular matrix accumulation in mouse mesangial cells exposed to high glucose via the ERK1\/2 pathway","volume":"14","author":"Zhang","year":"2013","journal-title":"BMC Nephrol"},{"key":"26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.stemcr.2014.03.008","article-title":"Cell-state transitions regulated by SLUG are critical for tissue regeneration and tumor initiation","volume":"2","author":"Kuperwasser","year":"2014","journal-title":"Stem Cell Reports"},{"key":"27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016","volume":"166","author":"Thiery","year":"2016","journal-title":"Cell"},{"key":"28","doi-asserted-by":"crossref","first-page":"44941","DOI":"10.1038\/srep44941","article-title":"Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients","volume":"7","author":"Passlick-Deetjen","year":"2017","journal-title":"Sci Rep"},{"key":"29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Giancotti","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"30","doi-asserted-by":"crossref","first-page":"e90374","DOI":"10.1371\/journal.pone.0090374","article-title":"Cilengitide inhibits attachment and invasion of malignant pleural mesothelioma cells through antagonism of integrins alphavbeta3 and alphavbeta5","volume":"9","author":"Reid","year":"2014","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bbamcr.2017.04.002","article-title":"Membrane-type matrix metalloproteases as diverse effectors of cancer progression","volume":"1864","author":"Lehti","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2407-6-130","article-title":"Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis","volume":"6","author":"Santoni","year":"2006","journal-title":"BMC Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1078-0432.CCR-16-0844","article-title":"Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma","volume":"23","author":"Johnston","year":"2017","journal-title":"Clin Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"L272","DOI":"10.1152\/ajplung.00358.2007","article-title":"Lung-selective gene responses to alveolar hypoxia: potential role for the bone morphogenetic antagonist gremlin in pulmonary hypertension","volume":"295","author":"McLoughlin","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.humpath.2015.02.006","article-title":"Prognostic factors in malignant pleural mesothelioma","volume":"46","author":"Davidson","year":"2015","journal-title":"Hum Pathol"},{"key":"36","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Gervais","year":"2016","journal-title":"Lancet"},{"key":"37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2012.06.011","article-title":"Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium","volume":"78","author":"Kindler","year":"2012","journal-title":"Lung Cancer"},{"key":"38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jtho.2016.01.014","article-title":"A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes","volume":"11","author":"Baas","year":"2016","journal-title":"J Thorac Oncol"},{"key":"39","first-page":"58","article-title":"The bone morphogenetic protein antagonist Gremlin is overexpressed in human malignant mesothelioma","volume":"27","author":"Wang","year":"2012","journal-title":"Oncol Rep"},{"key":"40","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1152\/ajpendo.00389.2012","article-title":"Muscle protein synthesis, mTORC1\/MAPK\/Hippo signaling, and capillary density are altered by blocking of myostatin and activins","volume":"304","author":"Ritvos","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00418-004-0701-1","article-title":"Establishment of permanent cell lines purified from human mesothelioma: morphological aspects, new marker expression and karyotypic analysis","volume":"122","author":"Spiliopoulos","year":"2004","journal-title":"Histochem Cell Biol"},{"key":"42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ajpath.2013.11.020","article-title":"Osteopontin promotes the invasive growth of melanoma cells by activating integrin alphavbeta3 and down-regulating tetraspanin CD9","volume":"184","author":"H\u00f6ltt\u00e4","year":"2014","journal-title":"Am J Pathol"},{"key":"43","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1091\/mbc.e13-11-0667","article-title":"Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton","volume":"25","author":"Lehti","year":"2014","journal-title":"Mol Biol Cell"},{"key":"44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1432-1033.1996.0239u.x","article-title":"Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate","volume":"239","author":"Keski-Oja","year":"1996","journal-title":"Eur J Biochem"},{"key":"45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/abio.1994.1042","article-title":"An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct","volume":"216","author":"Rifkin","year":"1994","journal-title":"Anal Biochem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:24:45Z","timestamp":1589207085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.21550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":45,"journal-issue":{"issue":"58","published-print":{"date-parts":[[2017,11,17]]}},"alternative-id":["21550","29228689"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.21550","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]}}}